Literature DB >> 22816542

The significance of heart rate turbulence in predicting major cardiovascular events in patients after myocardial infarction treated invasively.

Sylwia Cebula1, Beata Sredniawa, Jacek Kowalczyk, Agata Musialik-Lydka, Aleksandra Wozniak, Agnieszka Sedkowska, Andrzej Swiatkowski, Zbigniew Kalarus.   

Abstract

INTRODUCTION: The role of heart rate turbulence (HRT) related to baroreflex sensitivity in predicting mortality after myocardial infarction (MI) has been confirmed by several investigators. However, the significance of HRT in predicting major adverse cardiovascular events (MACE) following acute MI is unknown.
PURPOSE: To analyze the prognostic value of HRT and other independent risk factors associated with autonomic regulation of MACE.
METHODS: HRT was assessed based on 24-hour Holter recordings in 500 patients (pts) with acute MI treated invasively (352 M, aged 60.58 years). Turbulence onset (TO,%), slope (TS, ms/RR interval) and timing (TT) were calculated. TO ≥ 0, TS ≤ 2.5 and TT ≥ 10 were considered abnormal; classic and own categories were defined. Time domain heart rate variability (HRV) parameters were also calculated. Within 30.1 ± 15.1 months of follow-up, MACE occurred in 116 pts.
RESULTS: Abnormal TO, TS, and TT were significantly more frequent in patients with MACE (P < 0.05 for each parameter, classic and own categories). In long-term follow-up, the largest differences in MACE were observed in patients with own category comprising abnormal TO, TS, and TT. Combining HRT parameters with SDNN (total HRV index) augmented their predictive value. Independent risk factors for MACE were TT, SDNN and rMSSD (a parasympathetic activity index) (HR 2.44, 1.71 and 1.69 respectively; P < 0.05).
CONCLUSION: Abnormal HRT distinguishes patients at risk of MACE after MI. Own category encompassing three abnormal HRT parameters best differentiates patients at risk of MACE. Turbulence timing is a strong independent risk factor for MACE following MI. ©2012, Wiley Periodicals, Inc.

Entities:  

Mesh:

Year:  2012        PMID: 22816542      PMCID: PMC6932558          DOI: 10.1111/j.1542-474X.2012.00510.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  38 in total

1.  Heart-rate turbulence after ventricular premature beats as a predictor of mortality after acute myocardial infarction.

Authors:  G Schmidt; M Malik; P Barthel; R Schneider; K Ulm; L Rolnitzky; A J Camm; J T Bigger; A Schömig
Journal:  Lancet       Date:  1999-04-24       Impact factor: 79.321

2.  Heart rate variability. Standards of measurement, physiological interpretation, and clinical use. Task Force of the European Society of Cardiology and the North American Society of Pacing and Electrophysiology.

Authors: 
Journal:  Eur Heart J       Date:  1996-03       Impact factor: 29.983

3.  Prognostic significance of heart rate variability in post-myocardial infarction patients in the fibrinolytic era. The GISSI-2 results. Gruppo Italiano per lo Studio della Sopravvivenza nell' Infarto Miocardico.

Authors:  G Zuanetti; J M Neilson; R Latini; E Santoro; A P Maggioni; D J Ewing
Journal:  Circulation       Date:  1996-08-01       Impact factor: 29.690

4.  Heart rate turbulence slope reduction in imminent ventricular tachyarrhythmia and its implications.

Authors:  Mari A Watanabe
Journal:  J Cardiovasc Electrophysiol       Date:  2006-07

5.  Determinants of heart rate turbulence after ventricular premature beats in healthy volunteers.

Authors:  Jörg Otto Schwab; Gerrit Eichner; Osman Balta; Berndt Lüderitz
Journal:  Hellenic J Cardiol       Date:  2005 Jan-Feb

6.  Evaluation of heart-rate turbulence as a new prognostic marker in patients with chronic heart failure.

Authors:  Jiro Koyama; Jun Watanabe; Aki Yamada; Yoshito Koseki; Yuji Konno; Sunao Toda; Tsuyoshi Shinozaki; Masahito Miura; Mitsumasa Fukuchi; Mototsugu Ninomiya; Yutaka Kagaya; Kunio Shirato
Journal:  Circ J       Date:  2002-10       Impact factor: 2.993

7.  Deceleration capacity of heart rate as a predictor of mortality after myocardial infarction: cohort study.

Authors:  Axel Bauer; Jan W Kantelhardt; Petra Barthel; Raphael Schneider; Timo Mäkikallio; Kurt Ulm; Katerina Hnatkova; Albert Schömig; Heikki Huikuri; Armin Bunde; Marek Malik; Georg Schmidt
Journal:  Lancet       Date:  2006-05-20       Impact factor: 79.321

8.  Risk stratification after acute myocardial infarction by heart rate turbulence.

Authors:  Petra Barthel; Raphael Schneider; Axel Bauer; Kurt Ulm; Claus Schmitt; Albert Schömig; Georg Schmidt
Journal:  Circulation       Date:  2003-08-25       Impact factor: 29.690

9.  Effects of ventricular premature stimulus coupling interval on blood pressure and heart rate turbulence.

Authors:  Mari A Watanabe; Joseph E Marine; Robert Sheldon; Mark E Josephson
Journal:  Circulation       Date:  2002-07-16       Impact factor: 29.690

10.  Impact of myocardial salvage assessed by (99m)Tc-sestamibi scintigraphy on cardiac autonomic function in patients undergoing mechanical reperfusion therapy for acute myocardial infarction.

Authors:  Axel Bauer; Julinda Mehilli; Petra Barthel; Alexander Müller; Adnan Kastrati; Kurt Ulm; Albert Schömig; Marek Malik; Georg Schmidt
Journal:  JACC Cardiovasc Imaging       Date:  2009-04
View more
  2 in total

1.  Severity of arterial and chronic thromboembolic pulmonary hypertension is associated with impairment of heart rate turbulence.

Authors:  Piotr Bienias; Maciej Kostrubiec; Zuzanna Rymarczyk; Dariusz Korczak; Michał Ciurzyński; Marcin Kurzyna; Adam Torbicki; Anna Fijałkowska; Piotr Pruszczyk
Journal:  Ann Noninvasive Electrocardiol       Date:  2014-06-05       Impact factor: 1.468

2.  In-hospital heart rate turbulence and microvolt T-wave alternans abnormalities for prediction of early life-threatening ventricular arrhythmia after acute myocardial infarction.

Authors:  Mohamed Moussa Arisha; Nicolas Girerd; Samuel Chauveau; Didier Bresson; Alina Scridon; Eric Bonnefoy; Philippe Chevalier
Journal:  Ann Noninvasive Electrocardiol       Date:  2013-10-23       Impact factor: 1.468

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.